Technology News and Research

RSS

Edwards Lifesciences completes patient enrollment for transcatheter heart valve study

Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, today announced completion of enrollment in its 1,040-patient randomized controlled Investigational Device Exemption (IDE) study of the Edwards SAPIEN transcatheter heart valve.

1 Sep 2009

OHSU study reveals that fluoroquinolones may cause double vision

Highlights of September's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), include a 2009 review by the Academy of the safety and efficacy of a widely used corneal transplant procedure and a warning about an unusual but serious reaction to systemic fluroquinolones, a class of antibiotics used to treat a variety of bacterial infections.

1 Sep 2009

CT and PET scans carry a very real risk of radiation exposure

Thomas Dehn, M.D., FACR, executive vice president and chief medical officer of National Imaging Associates, a Magellan Health Services (Nasdaq: MGLN) company, today issued the following statement about the New England Journal of Medicine study published on Aug. 27 regarding patient exposure to ionizing radiation in imaging procedures.

1 Sep 2009

Surgeons successfully perform first-in-man results with four channel laparoscopic surgical platform

Officials with TransEnterix announce that surgeons from the United States and Paraguay have successfully performed first-in-man studies of its revolutionary single-incision, single-port, four-channel laparoscopic surgical platform called the SPIDER™ System.

1 Sep 2009

Cordis enrolls first patient in the CYPRESS clinical study

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.

31 Aug 2009

TriZetto Group launches new version of CareAdvance Enterprise system

The TriZetto Group, Inc. today announced the general availability of its CareAdvance Enterprise® 4.6 system, the new version of the company’s health management platform for healthcare payer organizations.

31 Aug 2009

MabCure featured in the August edition of Biotechnology Focus magazine

MabCure, Inc. (“MabCure”), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, has been featured in the August edition of Biotechnology Focus, Canada's oldest and most successful magazine serving the Canadian life science industry.

31 Aug 2009

Navicure to provide clearinghouse services for three more clients

Navicure, a leading Internet-based medical claims clearinghouse for physician practices, today announced the addition of three South Carolina-based practices to its client roster. Lexington Heart Clinic, Premier Surgical Services, PA, and Sunshine Pediatrics all selected Navicure’s award-winning account receivables management solutions to help streamline and better manage the claims submission process.

31 Aug 2009

Illumina delivers its first individual genome sequence to Dr. Hermann Hauser

Illumina, Inc. today announced that it has delivered Hermann Hauser’s genome sequence. Dr. Hauser, Partner, Amadeus Capital Partners Ltd, is the first consumer to purchase Illumina’s individual genome sequencing service working with his physician, Michael Nova, MD, of Pathway Genomics.

From Illumina, Inc. 31 Aug 2009

XerGame products to be showcased at the US Open Tennis Championships

XerTech Inc., a leading manufacturer, seller, and distributer of cutting-edge, interactive fitness systems, today announced that it will showcase its XerGame products at the US Open Tennis Championships, starting today, August 31, and running through the end of the event on September 13, 2009.

31 Aug 2009

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

The newly formed Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications in healthcare, invites interested pathology professionals to join them for the fifth annual Pathology Visions conference, to be held September 13-15 in San Diego, CA, at the Marriott Hotel and Marina.

31 Aug 2009

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

BioNeutral Group, Inc. has expanded its relationship with the Chertoff Group (Washington, DC). Beginning September 1, 2009, two senior members of the Chertoff Group will provide dedicated strategic and operational advisory services to BioNeutral to enhance the company’s strategic alliances, corporate operations, product testing, regulatory approvals, capital strategies and sales to the public and private sectors.

31 Aug 2009

Four additional patents filed by Lifeline Biotechnologies for its First Warning System methods and technology

Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO) today announced that it has filed four additional patents on its First Warning System™ methods and technology.

31 Aug 2009

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

Celladon Corporation and Momentum Research, Inc. today announced completion of enrollment of the phase 2 double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research is Celladon’s consulting and management organization with clinical expertise in the development of cardiovascular products and trials.

31 Aug 2009

Sonomax Hearing Healthcare completes Phase II trials of a delivery mechanism that inflates a V3 earplug successfully

Sonomax Hearing Healthcare Inc. (SHH:TSX Venture Exchange) is proud to announce that it has successfully passed its Phase II milestone, proof-of-performance of a delivery mechanism that inflates a V3 earplug as per fit function criteria.

31 Aug 2009

Highest Growth Potential Award given to Sundia MediTech Company

Sundia MediTech Company, a leading pharmaceutical R&D outsourcing Service Company in China, announced today that it received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26.

31 Aug 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

DSG finds place in the Inc. 500 list

The Inc. 500, which ranks the fastest growing U.S. privately held companies, announced that DSG reached No. 82 in the nation, making it the fastest growing privately held company in the Philadelphia area. As an Inc. 500 honoree, DSG shares a prestigious pedigree with such notable companies as Intuit, Microsoft, and Oracle.

31 Aug 2009

Veeva Systems bags order from three new customers

With the macro U.S. economy starting to show signs of recovery, the life sciences sector is reaching for new remedies to cure its financial ills.

31 Aug 2009

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

31 Aug 2009

Technology News and Research

Edwards Lifesciences completes patient enrollment for transcatheter heart valve study

OHSU study reveals that fluoroquinolones may cause double vision

CT and PET scans carry a very real risk of radiation exposure

Surgeons successfully perform first-in-man results with four channel laparoscopic surgical platform

Cordis enrolls first patient in the CYPRESS clinical study

TriZetto Group launches new version of CareAdvance Enterprise system

MabCure featured in the August edition of Biotechnology Focus magazine

Navicure to provide clearinghouse services for three more clients

Illumina delivers its first individual genome sequence to Dr. Hermann Hauser

XerGame products to be showcased at the US Open Tennis Championships

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

Four additional patents filed by Lifeline Biotechnologies for its First Warning System methods and technology

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

Sonomax Hearing Healthcare completes Phase II trials of a delivery mechanism that inflates a V3 earplug successfully

Highest Growth Potential Award given to Sundia MediTech Company

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

DSG finds place in the Inc. 500 list

Veeva Systems bags order from three new customers

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News